Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

ADHD Medications: A Look at Their Safety Profile

The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.

Joan Daughton, MD

Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents

Podcast

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

ADHD with ASD and without it: Should they be treated differently?

Results will be included an a final analysis of safety and efficacy data for CTx-1301, which will be included in a NDA submission with the FDA, stated Cingulate Inc.

Marian Freedman;Jon Matthew Farber, MD

Digital therapeutics and what they can do for mental health

"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."

Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more

Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.

Image Credit: © Artur - © Artur - stock.adobe.com.

FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Related Content

ADHD Medications: A Look at Their Safety Profile

The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.

Joan Daughton, MD

Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents

Podcast

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

ADHD with ASD and without it: Should they be treated differently?

Results will be included an a final analysis of safety and efficacy data for CTx-1301, which will be included in a NDA submission with the FDA, stated Cingulate Inc.

Marian Freedman;Jon Matthew Farber, MD

Digital therapeutics and what they can do for mental health

"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."

Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more

Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.